✦ LIBER ✦

New class of drugs help target NO to cancer cells

✍ Scribed by I van Oransk

Book ID: 117782902
Publisher: The Lancet
Year: 2003
Tongue: English
Weight: 143 KB
Volume: 4
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(03)01125-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aurora Kinase Inhibitors: A New Class of

Aurora Kinase Inhibitors: A New Class of Targeted Drugs in Cancer

✍ Oliver Gautschi; Philip C. Mack; Angela M. Davies; Primo N. Lara Jr; David R. Ga 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 632 KB

Targeting cancer-initiating cell drug-re

Targeting cancer-initiating cell drug-resistance: a roadmap to a new-generation of cancer therapies?

✍ Angela Alama; Anna Maria Orengo; Silvano Ferrini; Rosaria Gangemi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 626 KB

Cancer Drug Design and Discovery || A Ne

Cancer Drug Design and Discovery || A New Generation of Cell-Targeted Drugs for Cancer Treatment

✍ Arimondo, Paola B. 📂 Article 📅 2014 🏛 Elsevier ⚖ 750 KB

Getting to the Source: Selective Drug Ta

Getting to the Source: Selective Drug Targeting of Cancer Stem Cells

✍ Ismail, Fatima; Winkler, David A. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 603 KB

A New Approach for Enhancing Differentia

A New Approach for Enhancing Differential Selectivity of Drugs to Cancer Cells

✍ Duvvuri, Muralikrishna; Konkar, Samidha; Hong, Kwon Ho; Blagg, Brian S. J.; Kris 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 275 KB

Drug Resistance in Cancer Cells || Mecha

Drug Resistance in Cancer Cells || Mechanisms of Resistance to Targeted Tyrosine Kinase Inhibitors

✍ Siddik, Zahid H.; Mehta, Kapil 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 663 KB

It was estimated that in 2008, 1,437,180 patients would receive a new cancer diagnosisand 565,650individualswould die of cancer (Jemal et al. 2008).Since the vast majority of patients dying of cancer will have had anticancer therapy, both c- ventional chemotherapy and novel targeted therapy, it can